A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds. . . . → Read More: Start-Up Developing Efficient RNA Process, Raises $12M
|
|||||
       
 |
A biotechnology company designing treatments for inherited eye diseases with Crispr gene editing is raising €75 million in venture financing. . . . → Read More: Eye Disease Gene-Therapy Biotech Adds Venture Funds  Comments are closed  Finance, New products  biomedical, biotechnology, equity, Europe, genomics, investment, life sciences, pharmaceuticals, venture capital 
A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds Comments are closed Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, heart disease, investment, life sciences, nanotechnology, pharmaceuticals, preclinical, university, venture capital 
A new enterprise using digital and synthetic biology to create sustainable chemicals at industrial scale is raising $5 million in pre-seed round funds. . . . → Read More: Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds One comment - (Comments are closed) Finance, New products agriculture, biotechnology, carbon capture, chemistry, energy, engineering, entrepreneurs, equity, genomics, investment, life sciences, manufacturing, mathematics, patent, physical sciences, venture capital 
A new biotechnology company demonstrated in lab mice its therapy for glioblastoma, an aggressive brain cancer, that overcomes limitations of current treatments. . . . → Read More: Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M Comments are closed Finance, New products biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, physical sciences, preclinical, university, venture capital 
Two biotechnology companies say they discovered a peptide molecule with antimicrobial properties for faster identification and containment of food contamination outbreaks. . . . → Read More: Biotechs Discover Antimicrobial Peptide for Food Safety Comments are closed Finance, Joint ventures/collaborations, New products agriculture, biotechnology, engineering, equity, genomics, investment, life sciences, software, venture capital 
While venture capital funding for digital health start-ups worldwide is down compared to last year, the pace so far in 2022 remains on an historically strong track. . . . → Read More: Infographic – Digital Health Keeps Clicking in 2022 Comments are closed Finance computer science, engineering, entrepreneurs, equity, investment, mathematics, medical device, physical sciences, software, statistics, venture capital 
A developer of therapies produced with synthetic biology for diseases linked to microbes in the gut is raising $15 million in seed financing. . . . → Read More: Synthetic Bio Microbiome Biotech Gains $15M in Seed Funds One comment - (Comments are closed) Finance biomedical, biotechnology, cancer, clinical trials, entrepreneurs, equity, investment, pharmaceuticals, venture capital 
The first half half of 2022 shows venture investments in U.S. biotechnology start-ups cooled from the blistering pace of last year, but biotech remains a robust sector. . . . → Read More: Infographic – US Biotech Investments Stay Strong One comment - (Comments are closed) Finance biotechnology, economics, entrepreneurs, equity, investment, statistics, venture capital 
A start-up company designing and testing precise proteins within live animals to speed creation of new therapeutics is raising $40 million in its first venture round. . . . → Read More: Precision Protein Design Start-Up Gains $40M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, chemistry, engineering, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, physical sciences, university, venture capital |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
